DK375187A - PREPARATION OF HUMAN ANTITHROMBIN III (ATIII), SUCH VECTORS AND HOST CELLS, SOFTWARE PROVIDED BIOLOGICALLY ACTIVE ATIII AND PHARMACEUTICALS, CONTAINING THIS - Google Patents

PREPARATION OF HUMAN ANTITHROMBIN III (ATIII), SUCH VECTORS AND HOST CELLS, SOFTWARE PROVIDED BIOLOGICALLY ACTIVE ATIII AND PHARMACEUTICALS, CONTAINING THIS

Info

Publication number
DK375187A
DK375187A DK375187A DK375187A DK375187A DK 375187 A DK375187 A DK 375187A DK 375187 A DK375187 A DK 375187A DK 375187 A DK375187 A DK 375187A DK 375187 A DK375187 A DK 375187A
Authority
DK
Denmark
Prior art keywords
atiii
vectors
antithrombin iii
pharmaceuticals
preparation
Prior art date
Application number
DK375187A
Other languages
Danish (da)
Other versions
DK174993B1 (en
DK375187D0 (en
Inventor
Gerd Zettlmeissl
Michael Broeker
Hermann Regg
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of DK375187D0 publication Critical patent/DK375187D0/en
Publication of DK375187A publication Critical patent/DK375187A/en
Application granted granted Critical
Publication of DK174993B1 publication Critical patent/DK174993B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121Serpins
    • C07K14/8128Antithrombin III
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/10Plasmid DNA
    • C12N2800/108Plasmid DNA episomal vectors

Abstract

Human antithrombin III (ATIII) which has progressive inhibitory activity and is stimulated by heparin is advantageously obtained by expression after cotransfection of mammalian cells whose dihydrofolate reductase (DHFR) activity is deficient (dhfr<->) with a) vectors which contain the ATIII cDNA and b) vectors which harbour the DHFR gene, especially after gene amplification with methotrexate.
DK198703751A 1986-07-19 1987-07-17 Process for Preparation of Human Antithrombin III (ATIII) and Suitable Vectors and Host Cells DK174993B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3624453 1986-07-19
DE19863624453 DE3624453A1 (en) 1986-07-19 1986-07-19 METHOD FOR THE PRODUCTION OF HUMAN ANTITHROMBIN III (ATIII), VECTORS AND Host CELLS SUITABLE FOR THEM, BIOLOGICALLY ACTIVE ATIII, AND THE MEDICINAL PRODUCT CONTAINING THEM

Publications (3)

Publication Number Publication Date
DK375187D0 DK375187D0 (en) 1987-07-17
DK375187A true DK375187A (en) 1988-01-20
DK174993B1 DK174993B1 (en) 2004-04-13

Family

ID=6305549

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198703751A DK174993B1 (en) 1986-07-19 1987-07-17 Process for Preparation of Human Antithrombin III (ATIII) and Suitable Vectors and Host Cells

Country Status (11)

Country Link
EP (1) EP0256302B1 (en)
JP (2) JP2721158B2 (en)
AT (1) ATE85348T1 (en)
AU (1) AU610830B2 (en)
CA (1) CA1305932C (en)
DE (2) DE3624453A1 (en)
DK (1) DK174993B1 (en)
ES (1) ES2053476T3 (en)
FI (1) FI94425C (en)
GR (1) GR3007700T3 (en)
PT (1) PT85346B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03215430A (en) * 1990-01-19 1991-09-20 Kita Kiyoshi Anti-coagulant for articular cavity
DE3901917A1 (en) * 1989-01-24 1990-07-26 Behringwerke Ag MUTANTS OF HUMAN ANTITHROMBIN III
MXPA04005191A (en) * 2001-11-28 2005-04-29 Sandoz Ag Method for producing a recombinant polypeptide.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS597693B2 (en) * 1978-01-07 1984-02-20 株式会社ミドリ十字 Antithrombin preparation and its manufacturing method
JPS5846100A (en) * 1981-09-11 1983-03-17 Agency Of Ind Science & Technol Plasmid vector having three kinds of marker and its preparation
GB2116183B (en) * 1982-03-03 1985-06-05 Genentech Inc Human antithrombin iii dna sequences therefore expression vehicles and cloning vectors containing such sequences and cell cultures transformed thereby a process for expressing human antithrombin iii and pharmaceutical compositions comprising it
DE3382068D1 (en) * 1982-03-15 1991-01-31 Univ Columbia METHOD FOR INTRODUCING CLONED AMPLIFICABLE GENES IN EUKARYOTIC CELLS AND FOR THE PRODUCTION OF PROTEIN PRODUCTS.
IL73854A0 (en) * 1983-12-27 1985-03-31 Genetics Inst Vectors containing accessory dna for transformation of eucaryotic cells
IL71691A (en) * 1984-04-27 1991-04-15 Yeda Res & Dev Production of interferon-ypsilon
US4656254A (en) * 1985-12-02 1987-04-07 Miles Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor and antithrombin III

Also Published As

Publication number Publication date
FI94425B (en) 1995-05-31
ES2053476T3 (en) 1994-08-01
FI873153A (en) 1988-01-20
ATE85348T1 (en) 1993-02-15
EP0256302A2 (en) 1988-02-24
AU7577387A (en) 1988-03-03
CA1305932C (en) 1992-08-04
DE3624453A1 (en) 1988-01-28
FI873153A0 (en) 1987-07-16
AU610830B2 (en) 1991-05-30
JP2798659B2 (en) 1998-09-17
JPH09117293A (en) 1997-05-06
EP0256302A3 (en) 1989-11-02
JP2721158B2 (en) 1998-03-04
PT85346B (en) 1990-06-29
DK174993B1 (en) 2004-04-13
PT85346A (en) 1987-08-01
JPS6344898A (en) 1988-02-25
GR3007700T3 (en) 1993-08-31
EP0256302B1 (en) 1993-02-03
DK375187D0 (en) 1987-07-17
FI94425C (en) 1995-09-11
DE3783968D1 (en) 1993-03-18

Similar Documents

Publication Publication Date Title
ATE37375T1 (en) PHOSPHONYL HYDROXYACYL AMINO ACID DERIVATIVES AND THEIR USE AS ANTIHYPERTENSIVES.
DK410681A (en) PROCEDURE FOR THE PREPARATION OF AMIDINE DERIVATIVES OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS
DE3779206D1 (en) HUMAN ERYTHROPOIETIN GENE: HIGH LEVEL EXPRESSION IN STABLY TRANSFECTED SUCTION CELLS.
ES8800250A1 (en) Substituted propane-phosphonous acid compounds.
NZ215414A (en) Cyclosporins as pharmaceuticals
CA2027206A1 (en) Sulphonylaminocarbonyltriazolinones
DE3785684T2 (en) Pyrrolidinamide derivatives of acylamino acid, pharmaceutical composition and use.
DE3484360D1 (en) STABILIZED AQUEOUS FORMULATIONS OF SULFONYL UREAS.
DE68920683T2 (en) Integrated type of optical node and optical messaging system using the same.
ATE53206T1 (en) ALPHA-ARYL-4-(4,5-DIHYDRO-3,5-DIOXO-1,2,4-TRIAZ N-2(3H)-YL)BENZENACETONITRILE.
DK375187A (en) PREPARATION OF HUMAN ANTITHROMBIN III (ATIII), SUCH VECTORS AND HOST CELLS, SOFTWARE PROVIDED BIOLOGICALLY ACTIVE ATIII AND PHARMACEUTICALS, CONTAINING THIS
MY105571A (en) Herbicidal 1,3,5-triazin-2-ylaminocarbonylamino- sulfonylbenzoic esters, the preparation and use thereof.
AU7383387A (en) Amino acid derivatives
DE3577994D1 (en) MAGNIFYING VIRAL DNA SEGMENTS.
DE3851386D1 (en) Use of glycans as antiviral compounds.
DK0385391T3 (en) Expression vectors for the synthesis of proteins in Schizosaccharomyces pombe
IT1250410B (en) STEROID COMPOUNDS ACTIVE ON THE CARDIOVASCULAR SYSTEM
FI952287A (en) Process for the preparation of 2-amino-4,6-dichloropyrimidine
ES476837A1 (en) Antiallergic nitrogen bridge-head compounds
FR2602621B1 (en) ACTIVE RADIO RESPONSE CAPABLE OF HIGH AMPLIFICATION
DE3780157T2 (en) USE OF 4-BUTYL-1,2-DIPHENYL-PYRAZOLIDIN-3,5-DION AS AN ANTIVIRAL MEDICINE AGAINST AIDS.
IT1218855B (en) MONOLITHICALLY INTEGRATED SIGNAL AMPLIFIER STAGE, HIGH OUTPUT DYNAMICS
AR247730A1 (en) Derivatives of 2,2-dimethyl-cyclopropanecarboxylic acid
DK372686D0 (en) BENZODISULTAMER
IT209708Z2 (en) REGULATOR CALCULATOR PARTICULARLY FOR MAKING FURNISHING QUOTES.

Legal Events

Date Code Title Description
PUP Patent expired